贵州益佰制药股份有限公司2025年第一次临时股东大会决议公告

Meeting Overview - The first extraordinary general meeting of shareholders was held on September 5, 2025, at the administrative building of Guizhou Yibai Pharmaceutical Co., Ltd [2] - The meeting was chaired by the chairman, Ms. Dou Qiling, and utilized a combination of on-site and online voting methods, complying with the Company Law and the Articles of Association [2] Attendance and Voting - All current directors (6), supervisors (3), and the board secretary attended the meeting, with other senior executives present as well [3] - There were no rejected resolutions during the meeting [2] Resolutions Passed - The following resolutions were approved: 1. Cancellation of the Supervisory Board [3] 2. Amendments to the Articles of Association [3] 3. Amendments to the Rules of Procedure for Shareholders' Meetings [3] 4. Amendments to the Rules of Procedure for Board Meetings [4] 5. Amendments to the Independent Director Work System [4] 6. Amendments to the Compensation Management System for Directors and Senior Management [4] 7. Amendments to the Special System for Preventing the Controlling Shareholder and Related Parties from Occupying Company Funds [4] 8. Amendments to the External Investment Management System [4] 9. Amendments to the External Guarantee Management System [4] 10. Amendments to the Related Party Transaction Decision-Making System [4] 11. Amendments to the Fundraising Management Measures [5] 12. Amendments to the Entrusted Financial Management System [5] 13. Amendments to the Special System for Appointing Accounting Firms [5] 14. Amendments to the Implementation Rules for Cumulative Voting [5] Legal Verification - The meeting was witnessed by Beijing Junzhi Law Firm, confirming that the convening and proceedings of the meeting complied with relevant laws and regulations [6] - The resolutions made during the meeting were deemed legal and valid [6]